APA (7th ed.) Citation

RN, J., MM, J., N, K., JK, S., DM, R., GR, B., . . . JM, P. (2020). Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. Drug safety, 43(6), 567. https://doi.org/10.1007/s40264-020-00915-6

Chicago Style (17th ed.) Citation

RN, Jerome, Joly MM, Kennedy N, Shirey-Rice JK, Roden DM, Bernard GR, Holroyd KJ, Denny JC, and Pulley JM. "Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use." Drug Safety 43, no. 6 (2020): 567. https://doi.org/10.1007/s40264-020-00915-6.

MLA (9th ed.) Citation

RN, Jerome, et al. "Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use." Drug Safety, vol. 43, no. 6, 2020, p. 567, https://doi.org/10.1007/s40264-020-00915-6.